Quality & Compliance

Regulatory Framework

Pentaverse Biopharma’s operations are conducted within the regulatory framework applicable to the sale and distribution of non-prescription medicines in India, including the requirements of the Drugs and Cosmetics Act, 1940, and rules made thereunder, as applicable to its business activities, and the corporate law obligations under the Companies Act, 2013, administered by the Ministry of Corporate Affairs.

Corporate Compliance

As a private limited company registered under CIN U47720WB2026PTC289553, Pentaverse Biopharma is required to, and does, maintain:

  • Statutory registers and corporate records as prescribed under the Companies Act, 2013.

  • Timely filings with the Registrar of Companies and other applicable regulatory authorities.

  • Board oversight of the company’s operations, finances, and compliance obligations.

  • Internal documentation practices appropriate to a company operating in the pharmaceutical trade.

Product-Level Compliance

Pentaverse Biopharma’s business is limited to products classified as non-prescription (OTC) medicines under Indian law. The company’s approach to product-level compliance includes:

  • Sourcing exclusively from manufacturing and formulation partners holding valid licences under applicable drug control regulations.

  • Verifying that products marketed by the company fall within the permitted nonprescription category and are not scheduled substances requiring a medical prescription.

  • Maintaining documentation to support the regulatory status of products handled by the company.

Engagement With Regulators and Stakeholders

Pentaverse Biopharma recognises the importance of transparent and cooperative engagement with government authorities, regulatory bodies, and other stakeholders. The company is committed to responding promptly to regulatory inquiries and to providing the documentation and information reasonably required to demonstrate its compliance standing.

Product Enquiry